Tocilizumab for covid-19
Products billed under this code include Actemra IV.
Payment limit per 1 MG, by effective quarter, 2Q24 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Actemra IV.
Payment limit per 1 MG, by effective quarter, 2Q24 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Actemra IV | Genentech, Inc | 50242-0135-01 | 80 | $605.52 |
| Actemra IV | Genentech, Inc | 50242-0136-01 | 200 | $1,513.80 |
| Actemra IV | Genentech, Inc | 50242-0137-01 | 400 | $3,027.60 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $7.569 | $0.00 | 1 MG | Tocilizumab for covid-19 | v1, posted September 17, 2026 |
| 3Q26 | $7.569 | $0.00 | 1 MG | Tocilizumab for covid-19 | v1, posted September 15, 2026 |
| 2Q26 | $7.569 | $0.00 | 1 MG | Tocilizumab for covid-19 | v1, posted September 15, 2026 |
| 1Q26 | $7.569 | $0.00 | 1 MG | Tocilizumab for covid-19 | v1, posted September 15, 2026 |
| 4Q25 | $7.569 | $0.00 | 1 MG | Tocilizumab for covid-19 | v1, posted September 8, 2026 |
| 3Q25 | $7.569 | $0.00 | 1 MG | Tocilizumab for covid-19 | v1, posted March 10, 2026 |
| 2Q25 | $7.569 | $0.00 | 1 MG | Tocilizumab for covid-19 | v1, posted March 10, 2026 |
| 1Q25 | $7.569 | $0.00 | 1 MG | Tocilizumab for COVID-19 | v1, posted December 19, 2025 |
| 4Q24 | $7.569 | $0.00 | 1 MG | Tocilizumab for COVID-19 | v1, posted June 11, 2025 |
| 3Q24 | $7.569 | +$0.997 | 1 MG | Tocilizumab for COVID-19 | v1, posted June 11, 2025 |
| 2Q24 | $6.572 | – | 1 MG | Tocilizumab for COVID-19 | v1, posted March 11, 2025 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.